These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30694866)

  • 41. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease.
    Hagström H; Talbäck M; Andreasson A; Walldius G; Hammar N
    J Hepatol; 2020 Nov; 73(5):1023-1029. PubMed ID: 32621944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
    Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
    Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.
    Peleg N; Sneh Arbib O; Issachar A; Cohen-Naftaly M; Braun M; Shlomai A
    PLoS One; 2018; 13(8):e0202393. PubMed ID: 30106985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long working hours and increased risks of lean non-alcoholic fatty liver disease among Korean men and women.
    Lim GY; Chang Y; Kim I; Ryu S; Kwon R; Song J
    Sci Rep; 2023 Jul; 13(1):12230. PubMed ID: 37507409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity.
    Cho IY; Chang Y; Sung E; Kang JH; Wild SH; Byrne CD; Shin H; Ryu S
    Epidemiol Psychiatr Sci; 2021 Mar; 30():e23. PubMed ID: 33706839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population.
    Seo YG; Polyzos SA; Park KH; Mantzoros CS
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3322-3335. PubMed ID: 37164111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
    Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
    Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
    De Luca-Johnson J; Wangensteen KJ; Hanson J; Krawitt E; Wilcox R
    Dig Dis Sci; 2016 Sep; 61(9):2710-20. PubMed ID: 27262844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simple non-invasive scoring systems and histological scores in predicting mortality in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Liu CH; Ampuero J; Pavlides M; Wong VW; Fan JG; Bai L; Li H; Wu DB; Zhou LY; Du LY; Yang TK; Jiang W; Shi Y; Gil-Gómez A; Zhang WT; Liang JX; Romero-Gómez M; Tang H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1754-1768. PubMed ID: 33569851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoprotein(a) level predicts the development of nonalcoholic fatty liver disease in Korean adults: A retrospective longitudinal study.
    Nam JS; Park K; Baik SJ; Park JS
    Medicine (Baltimore); 2024 May; 103(22):e38340. PubMed ID: 39259121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Kim Y; Chang Y; Kwon MJ; Hong YS; Kim MK; Sohn W; Cho YK; Shin H; Wild SH; Byrne CD; Ryu S
    Am J Gastroenterol; 2021 Nov; 116(11):2270-2278. PubMed ID: 34114568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary sodium and potassium intake in relation to non-alcoholic fatty liver disease.
    Choi Y; Lee JE; Chang Y; Kim MK; Sung E; Shin H; Ryu S
    Br J Nutr; 2016 Oct; 116(8):1447-1456. PubMed ID: 27725000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study.
    Lee Y; Mun E; Park S; Lee W
    PLoS One; 2021; 16(7):e0255118. PubMed ID: 34297733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between cataract and fatty liver diseases from a nationwide cross-sectional study in South Korea.
    Kang KH; Shin D; Ryu IH; Kim JK; Lee IS; Koh K; Yoo TK
    Sci Rep; 2024 Jan; 14(1):77. PubMed ID: 38167592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.
    Singh A; Le P; Lopez R; Alkhouri N
    Hepatol Int; 2018 Jan; 12(1):37-43. PubMed ID: 29318450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
    Sebastiani G; Alshaalan R; Wong P; Rubino M; Salman A; Metrakos P; Deschenes M; Ghali P
    PLoS One; 2015; 10(6):e0128774. PubMed ID: 26083565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.